CHOO CHEE KONG enters CYTOMED THERAPEUTICS LTD with 2.59M shares across direct and indirect positions
This filing by CHOO CHEE KONG establishes the baseline for all future Form 4 insider transaction reports at CYTOMED THERAPEUTICS LTD.
Direct Indirect
Filed: 5/15/2026ACC: 0001493152-26-023401
Director10% Owner
Since Mar 2023
2.59M
Baseline shares
12% direct
318.32K
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
3
Security positions
2.27M indirect
Non-Derivative Holdings3
Ordinary Shares, no par value per share
IndirectShares owned2.08M
Ordinary Shares, no par value per share
IndirectShares owned194.11K
Ordinary Shares, no par value per share
DirectShares owned318.32K
Total
318.32K direct·2.27M indirect2.59M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares, no par value per share | 2.08M | Indirect |
| Ordinary Shares, no par value per share | 194.11K | Indirect |
| Ordinary Shares, no par value per share | 318.32K | Direct |
| Total | 2.59M | 318.32K direct·2.27M indirect |
Derivative Holdings0
No derivative holdings reported